Connect Biopharma reports positive Phase 2 asthma, COPD data for rademikibartNov 16Quarterly updateConnect Biopharma Holdings LtdDare Bioscience, Inc.
Traws reports final Phase 2a ratutrelvir data, completes TXM tablet bridging studyNov 12Clinical readoutTraws Pharma, Inc.
Traws Pharma files S-1 to register 135.1 million shares for Roth equity facilityOct 26FinancingTraws Pharma, Inc.Updated
Traws Pharma preps revised toxicology data for MHRA resubmission by Q3 2026Aug 14Quarterly updateTraws Pharma, Inc.
Traws Pharma files prospectus supplement for up to $5.58 million at-the-market stock saleJul 10FinancingTraws Pharma, Inc.
Traws Pharma stockholders approve share increase, elect directors at annual meetingJul 9PeopleTraws Pharma, Inc.